Braunschweig, July 19, 2023 – YUMAB announces its collaboration with InSCREENeX under the “exPDITE” funding project. The goal of the collaboration is to enable improved drug development for the individual treatment of patients with pancreatic cancer. To this end, patient-specific tissues will be propagated in the laboratory using InSCREENeX’s CI-SCREEN technology to identify new tumor targets using YUMAB’s proprietary antibody databases.
top of page
bottom of page